Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

429 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
SEA 2024 Standards for Global Control of Vascular Risk.
Mostaza JM, Pintó X, Armario P, Masana L, Real JT, Valdivielso P, Arrobas-Velilla T, Baeza-Trinidad R, Calmarza P, Cebollada J, Civera-Andrés M, Cuende Melero JI, Díaz-Díaz JL, Espíldora-Hernández J, Fernández Pardo J, Guijarro C, Jericó C, Laclaustra M, Lahoz C, López-Miranda J, Martínez-Hervás S, Muñiz-Grijalvo O, Páramo JA, Pascual V, Pedro-Botet J, Pérez-Martínez P, Puzo J. Mostaza JM, et al. Among authors: pinto x. Clin Investig Arterioscler. 2024 May-Jun;36(3):133-194. doi: 10.1016/j.arteri.2024.02.001. Epub 2024 Mar 15. Clin Investig Arterioscler. 2024. PMID: 38490888 Free article. English, Spanish.
[Apolipoprotein E polymorphism and coronary disease].
Peña R, M Mostaza J, Lahoz C, Jiménez J, Subirats E, Pinto X, Taboada M, López-Pastor A, del Estudio RAP g. Peña R, et al. Among authors: pinto x. Med Clin (Barc). 2001 May 19;116(18):681-5. doi: 10.1016/s0025-7753(01)71952-5. Med Clin (Barc). 2001. PMID: 11412677 Spanish.
Baseline levels of low-density lipoprotein cholesterol and lipoprotein (a) and the AvaII polymorphism of the low-density lipoprotein receptor gene influence the response of low-density lipoprotein cholesterol to pravastatin treatment.
Lahoz C, Peña R, Mostaza JM, Laguna F, García-Iglesias MF, Taboada M, Pintó X. Lahoz C, et al. Among authors: pinto x. Metabolism. 2005 Jun;54(6):741-7. doi: 10.1016/j.metabol.2004.12.020. Metabolism. 2005. PMID: 15931608 Clinical Trial.
[Emerging risk factors related to residual risk].
Millán J, Pedro-Botet J, Pintó X; en nombre de la Organización R3i (Residual Risk Reduction initiative) de España. Millán J, et al. Among authors: pinto x. Med Clin (Barc). 2011 Jun 11;137(2):92-3. doi: 10.1016/j.medcli.2010.09.025. Epub 2010 Dec 8. Med Clin (Barc). 2011. PMID: 21145077 Spanish. No abstract available.
429 results